COSM / Cosmos Health Inc. - Institutionelt ejerskab - Købere

Cosmos Health Inc.
US ˙ NasdaqCM ˙ US2214133058

Institutionelt og fondsejerskab - Købere

Større indehavere, der har åbnet nye stillinger i Cosmos Health Inc., omfatter Citadel Advisors Llc, og Citigroup Inc .

Denne side viser ændringer i ejerskabsstrukturen ved at notere institutioner, fonde og større aktionærer, der har øget deres beholdning eller åbnet nye positioner i den seneste rapporteringsperiode. Grønne rækker angiver nye positioner. Klik på linket ikon for at se den fulde transaktionshistorik.

Opgrader for at låse op for premium-data.

Fil dato Kilde Investor Type Gennemsnitlig pris
(Øst)
Aktier Δ Aktier
(%)
Rapporteret
Værdi
($1000)
Δ Værdi
(%)
Port Alloc
(%)
2025-08-14 13F Bank Of America Corp /de/ 205 13,26 0
2025-08-14 13F Citadel Advisors Llc 96.731 41
2025-08-18 13F/A National Bank Of Canada /fi/ 6.357 3
2025-08-14 13F Fmr Llc 0 0
2025-07-24 NP FCFMX - Fidelity Series Total Market Index Fund This fund is a listed as child fund of Fmr Llc and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value 28.538 14,61 13 -7,69
2025-08-14 13F UBS Group AG 62.377 1,14 26 0,00
2025-08-12 13F Proequities, Inc. 0 0
2025-08-14 13F Two Sigma Securities, Llc 16.039 7
2025-08-11 13F Citigroup Inc 2.678 1
2025-08-12 13F Virtu Financial LLC 104.422 0
2025-08-14 13F Jane Street Group, Llc 29.218 12
2025-08-12 13F XTX Topco Ltd 36.702 15
Other Listings
DE:V67A 0,55 €
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista